Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation

Non-albicans Candidemia Clinical Trial

Official title:

Retrospective Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01317394
• Other study ID #: 99078
• Status: Completed
• Phase: N/A
• First received: March 15, 2011
• Last updated: March 16, 2011
• Start date: December 2010
• Est. completion date: February 2011

Study information

• Verified date: March 2011
• Source: Taipei Medical University WanFang Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

This study is a retrospective research in order to compare and analysis the risk factor, clinical manifestation and efficacy of albicans candidemia by pulling medical records. We hope that this retrospective research will let us understand the method of treatment and prevention of albicans candidemia in order to improve the quality of healthcare.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: February 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

• above 20 years old

• hospital patients

• albicans candidemia patients

Exclusion Criteria:

• pregnant patients or patients under 16 years old

• liver cirrhosis and Child C

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Candidemia
• Non-albicans Candidemia

Locations

Country	Name	City	State
Taiwan	Taipei Medical University - WanFang Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
Taipei Medical University WanFang Hospital

Country where clinical trial is conducted

Taiwan,